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ABSTRACT 
 
THE INCIDENCE OF EARLY STAGE POSTOPERATIVE NAUSEA AND  
 
VOMITING FOLLOWING THE USE OF NITROUS OXIDE AND PROPHYLACTIC  
 
ANTIEMETIC THERAPY: IMPLICATIONS FOR CLINICAL PRACTICE 
 
by James Lanny Sullivan 
 
December 2015 
 
 Nitrous oxide (N2O) is a volatile agent currently used during the induction and 
maintenance of general anesthesia.  Since its discovery in 1786 by Dr. Priestly, it is the 
oldest volatile agent to find continued use in current practice (Kossick, 2014).  In 
conjunction with its extensive history, there is the debate regarding its emetic properties.  
Numerous studies have investigated the effect of nitrous oxide to produce postoperative 
nausea and vomiting (PONV) with varying and often conflicting results.  Generally 
speaking, nitrous oxide is theoretically an emetic and is believed to be associated with 
PONV (Tramer, Moore, & McQuay, 1996).  This has caused many providers to limit the 
continued use of this agent in their anesthetic technique.  The studies investigating this 
association have been largely inconclusive but nonetheless have significantly influenced 
the usage of nitrous oxide in current anesthesia practice.  Furthermore, current standards 
of practice promote the utilization of prophylactic antiemetic therapy to combat the 
sustained incidence of PONV following anesthesia and surgery.  Considering the current 
standards regarding antiemetic therapy, evidence suggests that the combination with N2O 
will decrease the incidence of PONV.
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CHAPTER I 
INTRODUCTION 
Development and Statement of Problem 
Background 
 The incidence of postoperative nausea and vomiting (PONV) has a substantial 
impact on healthcare facilities, providers, and patients.  Occurrences of PONV result in 
increased costs, utilization of resources, and decreased patient satisfaction (Kovac, 2013).  
These factors are paramount to the surgical population due to the notable incidence of 
PONV following anesthesia.  PONV occurs with a general incidence of 25-30% in all 
surgical patients, and ranges from 30% to 50% in the ambulatory surgery setting 
(Golembiewski, Chernin, & Chopra, 2005; Kovac, 2013).  This high prevalence has 
resulted in many providers and associations focusing on methods to reduce the risk of, 
and prevent the onset of PONV.  This focus on risk reduction and prevention has had a 
significant impact on nitrous oxide (N2O).  Considered to have emetic properties, the 
continued prevalence of a once highly utilized agent is now questionable among 
anesthesia professionals. 
Significance 
 Surviving innovation and technology, N2O is the oldest anesthetic agent still used 
in current practice.  Although it has an extensive record throughout the history of 
anesthesia as being both safe and effective, its usage has seen a significant decline over 
recent years.  This decline has been validated by Yoshimura and Ushijima (2005), who 
found a 48% decrease in the use of N2O from 97% in 1995 to 49% in 2004.  Though 
there are many possible reasons for this decline, it is closely associated to the perceived 
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relationship between N2O and postoperative nausea and vomiting (PONV).  The 
significance of this relationship has been examined in numerous studies producing no 
definitive conclusion, and often conflicting results.  Though the results are ambiguous, in 
a healthcare environment consumed with increased patient satisfaction and decreased 
cost, this stigma surrounding N2O has caused many providers to abandon its use. 
Problem Statement 
 Nitrous oxide is a safe, efficient, and valuable anesthetic agent offering 
considerable benefit to current practice but is often underused due to its perceived 
association with PONV.  Due to the high prevalence of PONV following surgery and 
general anesthesia, the current focus is engrossed in prevention and risk reduction rather 
than treatment.  This shift has resulted in the common practice of implementing 
prophylactic antiemetic therapy during the surgical procedure with the expectation of 
preventing the onset of PONV.  In lieu of this new practice, the catechism then is whether 
general anesthesia with N2O affects the incidence of PONV when the patient is treated 
with prophylactic antiemetic therapy. 
Theoretical Background 
Theoretical Foundation 
 There are numerous theories and philosophies that drive healthcare practice.  
They are helpful in creating a guideline for interpreting and understanding motivations 
that influence daily routines and practice methods.  Goodson (2011) proposes that 
theories “lend meaning, provide explanation, impose order, and organize logically the 
events that engulf healthcare professionals” (p. 78).  Understanding and utilizing these 
theories create the ability to implement new ideas and methodologies by healthcare 
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professionals and healthcare systems in order to improve quality and outcomes.  The 
nursing philosophies and theories are important to this project due to the desire to 
improve current practices and the overall healthcare environment.  A requirement of the 
Doctor of Nursing Practice (DNP) graduate is to influence positive change through 
interventions that are congruent with the expectations and desires of those we care for.  
These interventions are based on nursing theories that define the boundaries of nursing 
actions, providing structure and unity that improve the continuity of care along with the 
effectiveness of the interventions (Eldridge, 2011).  Ultimately, nursing theory 
establishes a holistic relationship between the provider and a patient encompassing the 
values and beliefs of both, in order to achieve the greatest outcome. 
Quality Improvement 
 In relation to nursing theories, this project is grounded on the Donabedian theory 
of total quality management.  Donabedian believed that quality could be defined and 
influenced using three distinct concepts that are dependent upon each other for success: 
structure, process, and outcomes (Donabedian, 1988; Edwardson, 2007).  He believed 
that these concepts are all affected by costs, expectations, and resource limitations, 
encompassing both direct and indirect variables while focusing on the most beneficial 
outcome (Anderson, 2011; Donabedian, 1988).  Particularly significant is Donabedian’s 
belief that quality management is a shared responsibility of the provider, consumer, and 
community (Donabedian, 1988).  In effect, Donabedian created a simplified model that 
can be readily and easily adapted to almost any circumstance, and closely resembles 
many of the proposed concepts of the new Affordable Care Act. 
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 The Donabedian theory was chosen as the foundation for this project due to its 
relevance with the current healthcare environment and focus on quality improvement.  
Donabedian insisted that his concepts of structure, process, and outcomes were critical to 
quality management in order to find the most efficient and legitimate processes that will 
provide the greatest benefit for the least cost to the patient (Anderson, 2011).  Using these 
concepts, he insisted that “good structure increases the likelihood of good process, and 
good process increases the likelihood of a good outcome” (Donabedian, 1988, p. 1745).  
In applying this model to the project, structure is represented by the qualifications and 
knowledge basis of the providers, while process signifies the degree in which providers 
conform to the standards of care and expectations of the facility and patients.  The 
objective, then, is to influence the structure and process in order to influence the 
outcomes. 
 The continuous rise in healthcare costs has created the development of new 
payment methods that are closely related to this project and chosen theory.  Cost and 
quality are synonymous in that lower quality and insufficiency coexist through wasteful 
care.  Donabedian (1988) stated that this is “directly harmful to health or is harmful by 
displacing more useful care” and that “the practice of optimal care requires added 
knowledge of costs, and also some method of weighing each added bit of expected 
usefulness against is corresponding costs” (p. 1745).  This has led to the recent creation 
of quality-based payment methods such as value based purchasing and the bundled 
payment initiative.  Both of these payment methods base provider and facility 
reimbursement on the perceived quality of care rather than quantity.  The sole purpose of 
this project is to decrease the cost of healthcare while improving the quality of care to the 
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patient.  Quality based payments highlight the significance of this project, serving to 
provide quality care in an efficient manner by decreasing the incidence of PONV, 
improving patient satisfaction, increasing the quality of care, and the added benefit of 
decreasing costs to both the provider and consumer.   
DNP Essentials 
Scientific Underpinnings for Practice 
 Nursing uses numerous models, concepts, and theories to guide practice.  They 
provide methods for understanding healthcare problems while also influencing 
interventions to alleviate these problems.  These models and theories establish 
frameworks for developing goals and boundaries that can be examined for effectiveness 
(Eldridge, 2011).  Of significance to this project is Peplau’s interpersonal model.  This 
model and project are fitting due to the sequential steps and underlying concepts that are 
required to reach a goal.  Peplau believed that the work of the nurse is fundamental to the 
patient regaining health and well-being (Peplau, 1997).  Together, the nurse and patient 
work toward mutually agreed-upon goals by defining the problems, clarifying the 
expectations, exploiting different practices, and developing a solution (Eldridge, 2011).  
This model is utilized in the project by establishing PONV as the problem, identifying 
efficiency and decreased PONV as the expectation, and by exploiting a different 
anesthetic technique in order to reach the desired goal.  Instituting this model establishes 
the groundwork for this project to meet the expectations of both the patient and provider. 
Organizational and Systems Leadership 
 A major focus of the DNP curriculum is the ongoing improvement of clinical 
nursing practice, health outcomes, and patient safety.  These goals are of considerable 
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importance to the current healthcare environment that is consumed with the rising cost of 
healthcare and maintaining patient satisfaction.  In recognition of these factors, 
Churchman’s systems model will be exploited in this project in an effort to attain these 
goals.  Churchman proposed the notion of considering an action without taking the 
action, suggesting that the action could be evaluated to estimate its probability of 
attaining a goal (Churchman, 1973).  This assumption led to a model that divides a 
system into five categories with the clients' interest representing the essence of the system 
(Petersen, 2011).  The categories consist of the client, environment, decision maker, 
planner, and measure of performance.  In relation to this project, the anesthesia providers 
illustrate the planner while the healthcare structure characterizes the environment.  
Applying this model, the planner seeks to improve the measure of performance in order 
to satisfy mutual objectives of the decision maker and environment. 
Clinical Scholarship 
 In healthcare and practice, proficiency and performance can never be improved 
without scrutiny.  Competency and advancement requires a willingness to challenge 
traditional views and methods in order to stimulate new knowledge that is significant to 
both healthcare and the profession (Tymkow, 2011).  Pertinent to achieving new 
knowledge and improving outcomes is the ability to evaluate current processes and to 
translate research into practice.  Employing these concepts inspires the implementation of 
quality improvement initiatives and clinical practice guidelines that enhance healthcare 
outcomes.  This project ventures to execute these concepts by combining a traditional 
method of anesthesia with current research to motivate evidence-based practice.   
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Instituting this method, the goal then is that this project will result in a practice strategy 
that improves provider productivity, anesthesia quality, and patient-centered outcomes. 
Information Systems/Technology 
 Technology and information systems are growing at an exponential rate 
throughout the healthcare field.  With a presidential executive order mandating electronic 
health records (EHR) in all healthcare systems, nursing informatics has become a top 
priority in healthcare and education.  Competency in nursing informatics has since been 
addressed in the National League for Nursing’s position statement and in the Institute of 
Medicine’s five quality and safety competencies (Burkart-Jayez, 2011; Institute of 
Medicine, 2011; National League for Nursing, 2015).  The informatics provide 
significant benefit to both practice and research by preventing errors, aggregating data, 
and providing better information to medical records.  This project takes advantage of the 
informatics produced in the EHR by using this system for outcomes management.  The 
applicable data is promptly recorded in the EHR and readily available.  The data is then 
capable of being gradually reviewed for outcome analysis.  This method of data 
collection, using the EHR, has the valuable effect of decreasing time consumption, 
preventing numerous errors, and expediting results. 
Objectives 
Purpose and Objectives 
 The purpose of this project is to evaluate the incidence of PONV following the 
administration of general anesthesia with N2O, when the patient is treated with 
prophylactic antiemetic therapy.  N2O is a safe, reliable, and efficient agent with a proven 
record of clinical benefits.  However, this agent does conceivably harbor emetic 
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properties.  With PONV considered by patients as a highly displeasing side effect of 
surgery, and costing hospital facilities thousands of dollars in lost revenue, N2O has lost 
favorability among many providers.  The primary objective then, is to determine the 
clinical significance of N2O and antiemetic therapy on the incidence of PONV.  If the 
project is successful in determining no clinical correlation between these variables, the 
secondary objective will be to increase provider knowledge in order to influence a change 
in practice.  This project will potentially result in improved patient satisfaction and 
outcomes, which, in conforming to the new method of value based reimbursement, will 
result in decreased cost and improved revenue for the provider and facility. 
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CHAPTER II 
REVIEW OF RELATED LITERATURE 
Postoperative Nausea and Vomiting 
Incidence and Significance 
 Postoperative nausea and vomiting is a common complication following surgery 
and anesthesia.  It is estimated to occur with a general incidence of 25-30% in all surgical 
patients, with nausea occurring more frequently at 40-50% and vomiting at 25-30% 
depending on the surgical population (Kovac, 2013).  This incidence can increase 
significantly with certain risk factors to a level of 70 to 80% (Fernandez-Guisasola, 
Gomez-Arneu, Cabrera, & Garcia del Valle, 2010).  These rates are significant to both 
healthcare providers and institutions due to the numerous risks associated with this 
complication.  Uncontrolled and persistent PONV can lead to unanticipated hospital 
admissions, electrolyte abnormalities and dehydration, tension on fresh suture lines, 
hematomas beneath surgical flaps, and increased risk of pulmonary aspiration (Apfel et 
al., 2012; Casey, 2013; Golembiewski et al., 2005).  These complications contribute not 
only to morbidity, but also affect patient satisfaction, delay patient discharge, and 
increase hospital costs (Norred, 2003).  In same day surgical centers, the annual cost of 
PONV is estimated to be between $250,000 and $1,500,000 (Winston, Rinehart, Riley, 
Vacchiano, & Pellegrini, 2003).  This makes it increasingly important to identify the risks 
that contribute to PONV. 
Pathogenesis 
 The pathogenesis of postoperative nausea and vomiting is believed to be 
multifactorial.  The most common pathways believed to be associated with PONV are the 
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chemoreceptor trigger zone (CTZ), the vomiting center, and the nucleus tractus solitarius 
(NTS), incorporating complex central and peripheral receptors and numerous 
neurotransmitters (Casey, 2013).  The major neurotransmitters impacting these pathways 
include dopamine, histamine, serotonin, and acetylcholine (Dahan, Niesters, Olofsen, 
Smith, & Overdyk, 2013).  These neurotransmitters exert their effects via receptors 
located throughout the body.  These receptors, essentially located in the pharynx, ear, gut, 
and brain, are triggered by numerous stimuli including motion, over distention or stretch, 
chemicals and toxins, emotions, smells, sights, or thoughts (Norred, 2003).  Any of these 
stimuli can then trigger the neural pathways to induce nausea and/or vomiting. 
Contributing Risk Factors 
 Several risk factors have been identified to contribute to the incidence of 
postoperative nausea and vomiting.  According to a consensus guideline developed by 
Gan et al. (2014), the strongest patient-specific predictor of PONV was female gender 
followed by history of PONV, nonsmoking status, history of motion sickness, and age 
greater than 50 years.  There has been some evidence showing an increased incidence of 
PONV due to anesthesia and surgery-related risk factors, including the use of volatile 
anesthetics, intraoperative and postoperative use of opioids, and the type and duration of 
surgical procedures (Gan, 2007).  Using a randomized controlled trial of 1,180 patients, 
Golembiewski et al. (2005) found that the strongest anesthesia-related risk factor for 
postoperative vomiting was the use of volatile anesthetic agents “and was mostly 
dependent on the duration of anesthesia, particularly in procedures lasting longer than 
three hours” (p. 1255).  This is in sharp contrast to Dahan et al. (2013) stating that  
“although inhalation anesthetics contribute significantly to the problem, opioids are the 
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major cause of PONV with an incidence of greater than 50% following balanced 
anesthesia” (p. 518).  Certain types of surgery also carry a greater risk of PONV with 
Helmy (1999) showing an incidence ranging from 44-77% following laparoscopic 
procedures.  This is in agreement with other studies showing higher incidences of PONV 
with specific procedures or anatomic areas. 
Risk Assessment 
 Due to the evident impact of PONV on healthcare costs and patient satisfaction, 
risk stratification is needed to better guide treatment and prevention.  In relation to the 
vast number of contributing factors, many risk factor models are cumbersome and time-
consuming for healthcare providers.  To combat this problem, simplified risk tools have 
been developed in order to increase the identification of patients at risk for experiencing 
PONV.  As noted by Kovac (2013), “one of the presently more popular scores for clinical 
and research purposes has been the simplified PONV risk score of Apfel et al.” (p. 1526).  
This is substantiated by the inclusion of this model in clinical guidelines such as the 
Society for Ambulatory Anesthesiology (Gan et al., 2014).  According to the American 
Society of Perianesthesia Nursing (ASPAN) (2006), this risk factor identification tool is 
supported by three validation studies and “provides better discrimination and calibration 
for the prediction of PONV” (p. 234).  This simplified risk identification tool identifies 
four predictors of PONV: female gender, nonsmoking status, history of previous PONV 
or motion sickness, and the use of postoperative opioids.  Using the risks identified, the 
incidence of PONV is then calculated based on the number of risk factors present.  For 
further clarification, PONV is classified into two distinct time frames: 0-6 hours (early 
PONV) and 6-48 hours (late PONV) (Tramer, Moore, & McQuay, 1997).  This 
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classification is again corroborated by its inclusion into specific clinical guidelines 
(ASPAN, 2006; Gan et al., 2014).  The stratification of these risk factors and time frames 
enhance the ability of the healthcare providers to prevent and treat postoperative nausea 
and vomiting. 
Nitrous Oxide 
Safety and Efficiency 
 In contrast to its association with PONV, the numerous clinical benefits of nitrous 
oxide maintain its considerable value in current anesthesia practice.  According to 
Billingham and Smith (2014) nitrous oxide improves all aspects of anesthesia by: 
enhancing the quality, speed, and safety of the induction phase; augmenting the quality of 
the maintenance phase; and expediting the recovery period by also reducing the 
occurrence of chronic postoperative pain.  All of this is accomplished with “minimal 
adverse effects and while also reducing overall costs” (p. 275).  This argument was 
strengthened by Joshi (2013) in stating that “overall, N2O can improve the quality and 
safety of general anesthesia as well as facilitate recovery with clinically insignificant 
adverse effects” (p. 11).  These qualities promote the continued use of N2O in current 
anesthesia practice. 
 One of the beneficial effects of N2O supporting its continued use is its ability to 
reduce anesthetic requirements.  A review by Myles, Leslie, Silbert, Paech, and Peyton 
(2004) declared, “the most notable advantage of N2O is that it allows a dose-reduction (in 
the order of 30-60%) of other more expensive and (possibly) more toxic anesthetic 
drugs” (p. 170).  The extensive analgesic property of N2O also causes a significant 
reduction in opioid requirements.  When compared to narcotics, 20% nitrous oxide has 
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been shown to produce pain relief equivalent to morphine without significant side effects 
(General Anesthetics, 2013).  A study by Parbrook in 1964 concluded that inhalation of 
20-25% N2O produced analgesic potency equivalent to 10mg – 15mg of intramuscular 
morphine (O’Sullivan & Benger, 2003; Parbrook, 1964).  This response was further 
established by Kariman et al. (2011) in a study showing no significant difference between 
50% N2O and fentanyl (2g/kg) in relieving moderate to severe pain.  These analgesic 
properties are highly valuable to anesthesia providers. 
 Nitrous oxide has also been shown to significantly improve induction and 
emergence of anesthesia when used in combination with other volatile anesthetic agents.  
This property, known as the second-gas effect, is routinely employed for the rapid 
induction of anesthesia in children.  The simultaneous administration of volatile 
anesthetics with N2O causes a greater uptake of the anesthetic agent in the alveoli and 
arterial blood, resulting in a clinically significant acceleration of induction (Nagelhout, 
2014).  According to Ewart (2010), the addition of N2O is associated “with a less 
problematic induction of anesthesia, with fewer adverse airway events and higher 
probability of first time insertion of laryngeal mask” (p. 215).  This phenomenon has 
been shown to significantly accelerate the reduction of accompanying volatile anesthetics 
during emergence of anesthesia, increasing the speed of emergence (Peyton et al., 2011).  
This results in clinically significant operating room efficiency.  These benefits make 
nitrous oxide highly valuable in modern anesthesia. 
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Nitrous Oxide and Postoperative Nausea and Vomiting 
Mechanisms of Action and Contributing Factors 
 The most significant controversy to nitrous oxide is its theoretical emetic 
potential.  Nitrous oxide is believed to stimulate PONV through numerous mechanisms.  
According to Tramer, Moore, and McQuay (1996) “the most likely mechanism was 
gastrointestinal distension by manual ventilation and N2O transfer to the gastrointestinal 
tract” as well as activation of “the medullary dopaminergic system and increases in 
cerebrospinal opioid peptides” (p. 186).  Other factors suggested to cause PONV include 
changes in middle ear pressure and bowel distention from diffusion of N2O into closed 
cavities (Golembiewski et al., 2005).  It is also hypothesized that the incidence of PONV 
following N2O exposure may be related to the dosage and duration.  A study observing 
137 women undergoing laparoscopic gynecologic surgery showed no significant 
difference between women receiving an oxygen/air mixture versus 50% N2O, but there 
was a 29% increase in the incidence of PONV when N2O was increased to 70% 
(Mraovic, Simurina, Sonicki, Skitarelic, Gan, 2008).  In regards to duration, a recent 
literature review by Peyton and Wu (2014) found that “the risk ratio of PONV increases 
approximately 20% per hour after the first 45 min of exposure to N2O” but duration of 
less than one hour produces little effect on this incidence (p. 1137).  However, the risk 
increase from N2O duration may be irrelevant, as the surgical duration has been shown to 
increase the risk of PONV by 60% for every 30-minute increase in time (Gan, 2007).  
While these mechanisms suggest an association between N2O and PONV, they are 
largely inconclusive. 
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Conflicting Results 
 Numerous studies have failed to show a significant correlation between N2O and 
PONV.  Evaluating two systematic reviews and four randomized controlled trials 
observing the relationship between N2O and PONV, Ewart (2010) concluded that this 
association is only evident in patients with a high baseline risk.  This conclusion is 
supported by a meta-analysis from Fernandez-Guisasola et al. (2010) showing that 
omitting nitrous oxide reduced PONV by 20% in high-risk groups but also showed that 
the incidence of PONV was high in both groups (33% N2O vs. 27% no N2O).  Another 
study observing the effect of N2O on forty female patients undergoing laparoscopic 
cholecystectomy, a procedure and population considered high risk, found no significant 
difference between groups with and without nitrous oxide (Ture, Takil, Eti, & Gogus, 
2007).  Furthermore, Pandit, Malviya, and Lewis (1995) observed no difference in the 
incidence and severity of PONV in children undergoing tonsillectomy and 
adenoidectomy, another procedure and population considered high risk, when N2O was 
eliminated during induction and maintenance of anesthesia.  This implies that omitting 
N2O to prevent PONV has no significant impact and thus should not impede its use in 
current practice. 
Postoperative Nausea and Vomiting Prophylaxis 
Risk Reduction and Efficiency 
 There is strong evidence supporting the prophylactic use of antiemetic therapy to 
prevent PONV.  Dexamethasone and ondansetron, in combination or alone, have both 
been shown to significantly reduce the risk of PONV and is now being used by many 
anesthesia providers (Gupta et al., 2003; Golembiewski et al., 2005).  This is supported 
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by Norred (2003) showing only a 7% incidence of vomiting, following prophylactic 
administration of ondansetron, in women undergoing laparoscopic surgery.  The 
incidence of PONV was further decreased to zero with multimodal management.  Gan 
(2007) sustains these findings with evidence concluding that the combination of 
ondansetron and dexamethasone prevented PONV in 97% of patients in the first 2 hours 
after extubation and 87% in the first 24 hours.  Considering the higher cost of care to the 
hospital and patient due to PONV, antiemetic prophylaxis may reduce overall PONV-
related costs (Pueyo, Lopez-Olaondo, Sanchez-Ledesma, Ortega, & Carrascosa, 2003).  
As noted by Gan et al. (2014), “given that several antiemetics are now generic and 
inexpensive, some experts suggest it may appropriate to give 1 or 2 antiemetics to all 
patients” (p. 88). 
Current Standards and Guidelines 
 With a general incidence of PONV at approximately 25-30%, and reaching as 
high as 70-80% in certain populations, the overall impact on the healthcare system is 
significant (Kovac, 2013).  It is considered by many patients to be the most undesirable 
symptom following surgery and “one of the most common reasons for poor patient 
satisfaction rating in the postoperative period” (Gan, Sloan, Dear, El-Moalem, & 
Lubarsky, 2001, p. 395).  In a healthcare culture largely focused on patient satisfaction, 
prevention of PONV has become a top priority for many anesthesia providers.  Many 
clinical guidelines now promote the prophylactic use of anti-emetic therapy, especially in 
high-risk settings (ASPAN, 2006).  Gan et al. (2014) points out that the goal of 
prophylactic anti-emetic therapy is “to decrease the incidence of PONV and thus patient-
related distress and reduce health care costs” (p. 85).  Though the Society for Ambulatory 
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Anesthesia suggests prophylactic therapy for those at moderate risk, others suggest 
prophylactic therapy should be utilized for all ambulatory surgical patients (Gan et al., 
2014; Joshi, 2013; Kovac, 2013).  Given the overall efficiency of prophylactic therapy 
and the ability to reduce healthcare cost while improving patient satisfaction, it would 
seem prudent to institute this treatment as the standard of care. 
Summary 
 Given the current evidence, it is hard to conclude the overall impact of nitrous 
oxide on postoperative nausea and vomiting.  This becomes even more obscure due to the 
overwhelming usage of propofol as the standard induction agent for anesthesia.  Joshi and 
Cunningham (2013) note that “the use of propofol for induction of anesthesia and 
antiemetic prophylaxis, which is the current standard of care, further negates the emetic 
effects of N2O”, further suggesting relatively little impact on the incidence of PONV (p. 
1264).  The beneficial effects of N2O to clinical practice maintain its relevance in a 
healthcare setting fascinated with patient satisfaction and cost efficiency.  With 
prophylactic antiemetic therapy as the standard of care, evidence supports that this, in 
combination with N2O, would meet those goals while having no significant impact on the 
incidence of PONV. 
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CHAPTER III 
METHODOLOGY 
Preliminary Procedures 
Population and Design 
 The inclusion criteria for this project consist of English-speaking adults between 
the ages of 18 and 65, presenting for surgery to the same day surgical unit.  All subjects 
must receive an anesthetic technique consisting of a volatile anesthetic agent 
(sevoflurane, desflurane, or isoflurane) in combination with N2O, as the primary 
anesthetic method, by either an Anesthesiologist or Certified Registered Nurse 
Anesthetist (CRNA).  Participants administered a regional anesthetic will be included, so 
long as the regional technique is used specifically for postoperative pain control and used 
in combination with the primary method described above.  These subjects must also 
receive either ondansetron (Zofran) or dexamethasone (Decadron), or a combination of 
both, immediately prior to or during the surgical procedure. At this time, the study is only 
concentrating on Early PONV, which is considered nausea and/or vomiting that occurs 
within the first 2 hours after surgery.  Late and Delayed PONV is a possibility for study 
at a later date.  Exclusion criteria will include any subject that does not receive either 
antiemetic therapy, alone or in combination, prior to the anesthesia end time.  All subjects 
considered having inpatient status, prior to the procedure, are excluded.  All subjects 
requiring admission to the intensive care unit or mechanical ventilation following the 
procedure are also excluded. 
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Setting 
 The setting for this study is a 512-bed, Level II Trauma Center in the Southeast 
United States.  The time frame selected includes a 12-month period, beginning June 30th 
of 2014 and concluding June 30th of 2015. 
Design 
 Following approval from the Institutional Review Board (IRB) of the hospital 
facility and university, this project will be carried out utilizing a retrospective chart 
review.  Subjects will be recruited by means of convenience sampling via the Electronic 
Patient Information Center (EPIC) software at the designated facility, with a minimum 
goal of 25 and maximum of 150.  Potential study participants will be determined using 
the EPIC software to identify subjects presenting for surgery, through the same day 
surgical unit, during the time period allotted.  At this level, the charts will then be 
individually analyzed for satisfaction of the remaining inclusion/exclusion criteria. 
Measurement Evaluation 
Data Collection and Procedures 
 Only de-identified data will be collected for subjects meeting the population 
criteria listed above.  The data collected will include the PONV risk factors outlined in 
the simplified PONV risk score system (Table 1) to include age, gender, and smoking 
status, history of PONV or motion sickness, administration of postoperative opioids, 
duration of anesthesia, and the type of surgery.  Data collected for outcome measurement 
will include the administration, timing, and dosage of a rescue antiemetic due to an 
incidence or complaint of nausea and/or vomiting, as well as readmission to the hospital 
within 24 hours following a surgical procedure due to a complaint of PONV. 
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Table 1 
Simplified PONV Risk Score System 
 
   Risk Factors Points 
 
 1. Female Gender 1 
 
 2. Non Smokers 1 
 
 3. History of PONV 1 
 4. Postoperative Opioids 1 
   Sum 0-4 
 
Note: Simplified PONV risk score system to predict the incidence of PONV. 
 
Data Analysis 
 The design of this study uses the simplified PONV risk score system to stratify 
subjects into low, medium, or high-risk categories based on their number of risk factors.  
An incidence of PONV will be considered positive if a subject requires the administration 
of a rescue antiemetic, due to a complaint or incidence of nausea and/or vomiting, within 
the first 2 hours following surgery.  The primary endpoint of this project evaluates the 
incidence of PONV for each assigned risk category (study group) and compares that data 
to the overall incidence of PONV, for the respective group (control group); low = 20%, 
medium = 40%, high = >60% (Table 2).  The significance between the study group and 
control group will be determined using the two-sample t-test with a significance level of a 
= 0.05.  Data will be further stratified by examining the influence of surgical duration and 
type of surgery on the incidence of PONV using the Chi-Square Test for Independence, 
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with a significance level of a = 0.05, as secondary endpoints.  Readmission to the hospital 
within 24 hours following a surgical procedure, due to a complaint of nausea and/or 
vomiting, will be collected as a tertiary endpoint for further risk and outcome 
stratification.  All data will be analyzed using QuickCalcs software from GraphPad 
Software, Incorporated.  
Table 2 
Incidence of PONV by Risk Category 
 
 Risk Category Incidence of PONV 
 
 
 Low = 0-1 Risk Factors < 20% 
 
 Moderate = 2 Risk Factors 40% 
 
 High = 3-4 Risk Factors > 60% 
 
 
Note: The average incidence of PONV based on the overall number of risk. 
 
Ethical Protection 
 All information and data will be de-identified throughout the process of this 
project.  All antiemetic therapies and anesthetic agents reviewed in this study are proven, 
safe, and accepted current practices in the field of anesthesia.  The data analysis of this 
proposed retrospective chart review occurs following surgical and anesthetic events, as 
well as post hospital discharge, thus posing no risks to participants.  Anesthesiologist and 
Certified Registered Nurse Anesthetist’s (CRNA) have extensive knowledge and training 
in the administration and monitoring of all medications and techniques involved. 
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CHAPTER IV 
ANALYSIS OF DATA 
Responsiveness and Effect Size 
Inclusion Criteria and Data Extraction 
 This study was designed as a retrospective chart review to evaluate the incidence 
of early stage postoperative nausea and vomiting.  Study subjects were recruited utilizing 
EPIC software after receiving approval from the institutional ethics committee of the 
medical center and university.  Initial investigation identified 2,122 subjects that 
presented to the same-day surgical unit for elective procedures between the dates of June 
30th of 2014 to June 30th of 2015.  Each chart was then individually analyzed for the 
correct criteria.  Of the 2,122 initial subjects, only 151 met the correct anesthetic and 
antiemetic requirements. 
 A total of 95 subjects, meeting all of the inclusion criteria, were enrolled in the 
study.  All subjects received a general anesthetic in combination with nitrous oxide as 
well as a prophylactic antiemetic treatment of ondansetron and/or dexamethasone, either 
during or immediately prior to the procedure.  Data collection included all factors known 
to be associated with the risk of developing PONV as identified by the Apfel simplified 
PONV risk score system (Apfel et al., 1999).  Also recorded were the duration of 
anesthesia and type of procedure, as these have been shown to influence the development 
of PONV.  The incidence of PONV was evaluated by recording the administration, 
dosage, and timing of any antiemetic given during the first two hours (0-2h) of the 
postoperative period.  There was no incidence of readmission recorded for this population 
during the time period of this study. 
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Statistical Analysis 
Primary Emetic Outcome 
 The patient demographics were evenly distributed for this study.  The average age 
of the study participants was 47 years, with males making up the majority at 53%.  Most 
of the subjects were non-smokers (73%), and only 2% had a history of PONV or motion 
sickness.  The main focus of this study is to evaluate the incidence of PONV following 
the use of general anesthesia with nitrous oxide when the patient has been treated with 
prophylactic antiemetics.  The goal is to determine if the use of nitrous oxide has any 
significant impact on the incidence of PONV when the patient has been treated with 
prophylactic antiemetic therapy, as this has become the current standard of care.  Due to 
the limited size of the study, the differences between means were analyzed using the one-
sample t-test and a 95% confidence interval.  Overall, the subjects in this population were 
found to have less PONV than the general surgical population, 20% compared to 30%, 
with a mean difference of 10% (95% CI: -0.181 to -0.018, P=0.0172).  These findings 
were then compared to a study by Koivuranta et al. (1997), measuring the incidence of 
PONV following general anesthesia with nitrous oxide, using the two-sample z-test and a 
95% confidence interval.  Again, the study population experienced less PONV, with a 
mean difference of 11% (95% CI: 0.014 to 0.206, P=0.025).  Based on both comparisons, 
these findings suggest that nitrous oxide has little to no effect on PONV when the patient 
is treated with prophylactic therapy. 
Simplified PONV Risk Score 
 For further stratification, the subjects of the study were distributed into one of 
three groups based on the number of risk(s) identified using the simplified PONV risk 
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score system: low (0-1), moderate (2), high (3-4).  The moderate risk category was 
largest with 53% of the population, followed by the high risk category at 26%, and the 
low risk category at 21%.  The incidences of PONV in these categories were compared to 
the average incidence of PONV of their respective category as established by Apfel et al. 
(1999) using the one-sample t-test and a 95% confidence interval.  The low risk category 
population of this study showed no real difference in the incidence of PONV, 15% 
compared to 10-20% in the general population (95% CI: -0.221 to 0.121, P=0.549).  
These statistics changed significantly however with the moderate and high risk category.  
The incidence of PONV in the moderate risk population of this study was 18% lower 
(95% CI: -0.299 to -0.061, P=0.0038) than its counterpart, with an incidence rate of 22% 
compared to 40%.  This was seen again in the high risk population of this study, with a 
difference of -40% (95% CI: -0.568 to -0.232, P=0.0001) for a PONV incidence of 20% 
compared to 60%. 
 For further diligence and sake of completeness, these populations were also 
compared to their respective categories from a study by Koivuranta et al. (1997) using the 
two-sample z-test and a 95% confidence interval.  The low and moderate risk populations 
of these two studies had little variation, with a difference of 9.5% (95% CI: -0.102 to 
0.291, P=0.344) and 7.5% (95% CI: -0.061 to 0.211, P=0.283) respectively.  As 
previously seen, this changes with the high risk category.  The incidence of PONV in the 
high risk population of this study is considerably lower than the respective population of 
the corresponding study, 20% versus 56%, with a cumulative difference of -36% (95% 
CI: 0.161 to 0.56, P=0.0004).   
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In evaluating these results, the evidence further suggests that nitrous oxide has minimal, 
if any, effect on PONV when the patient has been treated with prophylactic antiemetics. 
 After initially analyzing the data, the decision was made to evaluate the impact of 
nitrous oxide on the incidence of PONV between the three risk categories.  Using the 
two-sample t-test with a 95% confidence interval, the moderate and high risk populations 
were individually compared to the low risk population since this category is known to 
have the lowest incidence of PONV.  Remarkably, there was no compelling difference in 
the rate of PONV between the moderate or high risk populations when compared to the 
subjects of the low risk category.  The low versus moderate risk populations had a 
disparity of only 7% (95% CI: -0.284 to 0.144, P=0.516), while the low versus high risk 
population was only 5% (95% CI: -0.286 to 0.186, P=0.671).  Though these samples are 
small, the evidence again depreciates the hypothetical impact of nitrous oxide on the 
incidence of PONV. 
Gender Variability 
 The gender of the subjects in this population was recorded in order to evaluate 
this correlation to the results, since the female gender has been concluded to be the 
overall strongest predictor of PONV (Apfel et al., 2012).  The female gender constituted 
47% of the overall population with a PONV rate of 20% compared to the male gender at 
53% and a PONV rate also equal to 20%.  Interestingly, although the subject population 
and incidence rate were nearly equal, men contributed to 95% of the subjects in the low 
risk category, while women comprised 96% of the subjects in the high risk category.  The 
impact of gender on the incidence rate of PONV was evaluated using the fisher’s exact 
test and chi-square test for independence.  In utilizing both methods, it was determined 
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that gender had no contributable influence on the incidence rate (p=1.0, x2=0, df=1).  
With a relative risk of 1, it is concluded for this study that gender had no measurable 
influence on the occurrence of PONV. 
Procedure Effect 
 The type and duration of surgical procedures have recently been implicated as risk 
factors for nausea and vomiting in the postoperative period.  Predictive risk score models 
containing these new factors have even been developed and published in recent years 
(Smith, Smith, & Smith, 2012).  The relationship of these variables on the incidence of 
PONV was evaluated separately using the fisher’s exact test and chi-square test for 
independence.  Surgical duration was categorized into two groups: procedures lasting 60 
minutes or less, and procedures lasting greater than 60 minutes with a population 
distribution of 11% and 89% respectively.  Postoperative nausea and vomiting differed 
only slightly between the groups, with an incidence rate of 10% in the first group and 
21% in the latter.  This equates to a relative risk of 2.12, meaning that for a procedure 
lasting longer than 60 minutes there is 112% more risk of PONV.  Contrary to the 
findings, testing in this study revealed no definitive relationship between the duration of 
the procedure and PONV (P=0.68, x2=0.175, df=1). 
 Findings for the type of procedure differed slightly from the duration.  Surgical 
procedures were grouped into two categories for this study, abdominal/gynecological and 
neuro/ortho/vascular, since abdominal and gynecological procedures have shown to be 
strongly related to PONV (Apfel et al., 2012).  Abdominal procedures composed only 
33% of the population, but had a PONV rate of 32% compared to 14% for all other 
procedures.  This alone established a relative risk of 2.29 and a 129% increase in risk for 
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PONV.  The fisher’s exact test could not definitively rebuke a relationship between these 
variables (P=0.055).  This is seen again with the chi-square test for independence 
(x2=3.259, df=1, P=0.071), showing a weak relationship between the variables.  Though 
this evidence is not completely conclusive, it is reasonable to believe that there is a 
relationship between the type of procedure and incidence of PONV. 
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CHAPTER V 
SUMMARY 
Discussion of Results and Limitations 
 The evidence presented supports this study’s hypothesis that nitrous oxide has 
little to no effect on the incidence of PONV when the patient has been treated with 
prophylactic antiemetics.  The overall incidence of PONV in this population was 20% 
compared to the average of 30%.  The incidence rate for this population was also lower 
for every risk category of the simplified PONV risk score system.  This was especially 
apparent in the moderate and high-risk populations, in which this study produced a 
difference of -20% and -40% respectively, from the general population.  The results 
could even be slightly skewed since a positive incidence of PONV was captured as an 
administration of an antiemetic in the first two hours of the postoperative period.  The 
general postoperative orders stated to use ondansetron (Zofran) as the first line treatment 
for PONV, but it was found in this study that promethazine (Phenergan) was given first in 
seven of the nineteen positive cases.  This may have been due to preference given the 
known anxiolytic and sedative effects of this drug.  Also, other factors suspected of 
influencing the incidence of PONV, such as the administration of intraoperative opioids, 
were not included.  For the purpose of this study, only risk factors that have been proven 
and validated as strong predictors of PONV were included.  Although there are 
limitations to this study, due to the small sample size and retrospective technique, it can 
be reasonably speculated that the results will be similar in a larger population. 
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Conclusion 
Implications for Theory and Practice 
 With the current standard of using propofol for the induction of anesthesia and 
prophylactic coverage of antiemetics, there is no evidence to support the omission of 
nitrous oxide.  Propofol reduces the risk of PONV by 19% along with a 25% reduction by 
ondansetron and dexamethasone each, while omitting nitrous oxide only reduces the risk 
by 12% (Smith, Smith, & Smith, 2012).  As presented here, these variables sustained a 
substantially lower incidence of PONV than the general surgical population.  
Determining the significance of nitrous oxide on PONV, in regards to the variables of 
this study, would require a truly randomized controlled trial in which all subjects received 
exactly the same anesthetic and prophylactic treatment.  This will be considerably easier 
in the near future as, following this study, the EPIC system at the host facility will be 
initiating a search function in January of 2016 to aid in the retrieval of specific data and 
variables.  Features such as this notably increase the efficiency of initiating, evaluating, 
and disseminating critical information pertinent to the pursuit of improved performance 
and education. 
Future Direction 
 The continued, and increased use of nitrous oxide in current practice is supported 
by the evidence presented in this study. This agent has a proven track record in the field 
of anesthesia, and has been tested repeatedly over the decades.  It is the only general 
anesthetic that provides analgesic properties while reducing opioid requirements and 
dosages of other, more expensive volatile anesthetics (Myles et al., 2004).  
Complementary of its second-gas effect, it greatly reduces the induction and emergence 
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of anesthesia resulting in improved clinical efficiency (Nagelhout, 2014; Peyton et al., 
2011).  This establishes the potential to create a practice strategy that improves provider 
productivity, anesthesia quality, and patient-centered outcomes that will minimize 
expenditures resulting in decreased cost and improved revenue for the provider and 
facility.  This is highly valuable to the modern clinical setting, which is encompassed 
with decreasing cost and utilization of resources.  To gain a complete understanding of 
the clinical impact, future studies should incorporate a cost analysis of this technique in 
order to confirm the patient-specific and economical benefits.  In conclusion, nitrous 
oxide has been, and remains, an efficient and safe anesthetic that will continue to provide 
positive results in current practice. 
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APPENDIX A 
INSTITUTIONAL REVIEW BOARD NOTICE OF COMMITTEE ACTION 
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APPENDIX B 
 
INSTITUTIONAL REVIEW BOARD NOTICE OF COMMITTEE ACTION 
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APPENDIX C 
LOW RISK CATEGORY 
 
Gender Age Smoking Hx of PONV/ Duration Opioids + PONV 
 Status Motion Sickness (min) 
 
 
Male 65 Yes No 109 No No 
Male 60 Yes No 95 No No 
Male 40 No No 170 No Yes 
Male 33 Yes No 227 Yes No 
Male 25 No No 62 No No 
Male 35 Yes No 100 Yes Yes 
Female 65 Yes No 124 No No 
Male 20 Yes No 138 Yes No 
Male 54 Yes No 180 Yes No 
Male 65 No No 78 No No 
Male 36 Yes No 81 Yes No 
Male 28 No No 78 No No 
Male 55 No No 136 No No 
Male 30 Yes No 62 Yes No 
Male 60 No No 64 No No 
Male 38 Yes No 157 Yes No 
Male 20 No No 135 No No 
Male 20 Yes No 178 Yes No 
Male 53 Yes No 43 Yes No 
Male 38 Yes No 213 Yes No 
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APPENDIX D 
MODERATE RISK CATEGORY 
 
Gender Age Smoking Hx of PONV/ Duration Opioids + PONV 
  Status Motion Sickness (min) 
 
 
Female 64 No No 68 No No 
Male 52 No No 183 Yes No 
Male 66 No No 192 Yes Yes 
Male 19 No No 94 Yes Yes 
Male 62 No No 239 Yes No 
Male 65 No No 75 Yes No 
Female 29 Yes No 120 Yes No 
Female 30 Yes No 82 Yes Yes 
Male 61 No No 278 Yes No 
Female 61 Yes No 125 Yes No 
Male 18 No No 55 Yes No 
Male 51 No No 477 Yes Yes 
Female 61 No No 100 No No 
Female 58 Yes No 203 Yes No 
Female 64 No No 91 No No 
Female 56 Yes No 111 Yes Yes 
Male 45 No No 213 Yes Yes 
Male 54 No No 126 Yes No 
Female 56 Yes No 112 Yes No 
Male 58 No No 152 Yes No 
Female 61 No No 76 No No 
Female 65 No No 117 No No 
Male 59 No No 238 Yes Yes 
Female 49 Yes No 40 Yes No 
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Gender Age Smoking Hx of PONV/ Duration Opioids + PONV 
  Status Motion Sickness (min) 
 
 
Male 65 No No 165 Yes No 
Male 64 No No 160 Yes Yes 
Female 53 Yes No 80 Yes Yes 
Male 59 No No 139 Yes No 
Female 26 Yes No 52 Yes No 
Male 47 No No 103 Yes No 
Male 55 No No 135 Yes No 
Female 40 No No 67 No No 
Male 39 No No 130 Yes No 
Female 54 Yes No 91 Yes No 
Male 64 No No 128 Yes No 
Male 64 No No 62 Yes No 
Male 38 No No 198 Yes Yes 
Male 65 No No 55 Yes No 
Male 63 No No 64 Yes No 
Male 32 No No 204 Yes No 
Female 50 Yes No 130 Yes No 
Female 38 No No 155 No No 
Male 53 No No 190 Yes No 
Male 39 No No 59 Yes No 
Female 37 No No 75 No No 
Female 40 Yes No 84 Yes Yes 
Male 46 No No 160 Yes No 
Male 48 No No 134 Yes No 
Male 62 No No 43 Yes No 
Male 65 No No 142 Yes No 
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APPENDIX E 
HIGH RISK CATEGORY 
 
Gender Age Smoking Hx of PONV/ Duration Opioids + PONV 
  Status Motion Sickness (min) 
 
 
Female 55 Yes Yes 53 Yes Yes 
Female 19 No No 282 Yes Yes 
Female 58 No No 70 Yes No 
Female 43 No No 98 Yes No 
Female 29 No No 54 Yes No 
Female 29 No No 65 Yes No 
Female 19 No No 60 Yes No 
Female 35 No No 120 Yes No 
Female 63 No No 144 Yes No 
Female 60 No No 68 Yes No 
Female 63 No No 129 Yes No 
Female 53 No No 155 Yes No 
Female 46 No No 76 Yes Yes 
Female 46 No No 72 Yes No 
Female 57 No No 86 Yes No 
Female 21 No No 65 Yes Yes 
Female 62 No No 126 Yes No 
Female 38 No No 121 Yes No 
Female 28 No No 69 Yes Yes 
Female 51 No No 64 Yes No 
Female 64 No No 118 Yes No 
Female 64 No No 138 Yes No 
Female 32 No No 84 Yes No 
Male 24 No No 76 Yes No 
Female 29 No Yes 140 Yes No 
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APPENDIX F 
 
LITERATURE REVIEW TABLE 
 
HISTORY 
 
 
Author & Objective Design & Sample Findings 
Date   
 
 
Apfel et al. Risk validation Logistic regression Risk scores 
(1999) & simplification of 2,722 patients predict PONV 
 
Casey Continuing  Review article Universal 
(2013) development emetic therapy 
 
Dahan et al. Clinical  Textbook 
(2013) education 
 
Fernandez et al. Association of  Systematic review N2O has little 
(2010) N2O & PONV of 4,598 patients impact on 
   PONV 
 
Gan et al. Cost-benefit Questionnaire of Patients will 
(2001) analysis of PONV 80 patients pay $56-$100  
   for effective 
   antiemetic 
 
Golembrewski et al. Determining risk Clinical review Prophylactic 
(2005) for PONV  antiemetic 
   therapy is  
   effective 
 
Koivuranta et al. Estimate the  Survey of 1,107 Anti-emetics 
(1997) incidence of PONV patients given to 31% 
   of patients 
 
Kovac Managing PONV Review article Prophylaxis  
(2013)   for moderate 
   risk or higher 
 
Norred Antiemetic Review article Multimodal 
(2003) prophylaxis  approach 
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Author & Objective Design & Sample Findings 
Date 
 
 
Winston et al. Efficacy of 70% Randomized trial  PONV treated 
(2003) isopropyl alcohol of 100 healthy faster with  
 and ondansetron women alcohol than 
   ondansetron 
 
Yoshimura & Determine N2O Retrospective Use of N2O 
Ushijima consumption review has decreased 
(2005)   significantly 
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APPENDIX G 
 
LITERATURE REVIEW TABLE 
 
CONFLICTING DATA 
 
 
Author & Objective Design & Sample Findings 
Date 
 
 
Apfel et al. Risk factors to Systematic Independent  
(2012) predict PONV review predictors of 
   PONV 
 
Gan Management of Clinical Reduce base 
(2007) PONV guideline line risk  
   factors 
 
Gan et al. Management of Clinical Prophylaxis 
(2014) PONV guideline for moderate 
   to high risk 
   patients 
 
Helmy Prophylactic Randomised,  Incidence of  
(1999) efficacy of  double-blind PONV is 
 ondansetron comparison in  lower with 
  160 patients ondansetron 
 
Mraovic et al. Dose response Randomized,  N2O may 
(2008) of N2O controlled trial increase 
  of 137 patients PONV in dose 
   dependent  
   fashion 
  
Pandit et al. Role of N2O on Randomized trial No significant 
(1995) PONV in children of 60 children difference 
  undergoing with or 
  tonsillectomy without N2O 
 
Peyton & Wu Effect of  Systematic review No significant 
(2014) duration of N2O with regression of risk of PONV 
  risk ratio in 10,317 under an hour 
  patients of exposure 
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Author & Objective Design & Sample Findings 
Date 
 
 
Smith et al. Management of Review article No uniform 
(2012) PONV  standardized 
   approach for 
   managing 
   PONV 
 
Tramer et al. Effectiveness Meta-analysis N2O had no 
(1996) & safety of  of 24 randomized effect on  
 omitting N2O controlled trials PONV 
 
Ture et al. Effect of N2O Randomized N2O had no 
(2007) on PONV controlled trial influence on 
  of 40 females PONV 
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APPENDIX H 
 
LITERATURE REVIEW TABLE 
 
INTERVENTIONS AND IMPLICATIONS 
 
 
Author & Objective Design & Sample Findings 
Date 
 
 
ASPAN Prevention & Clinical practice Initiate PONV 
(2006) management of guideline prophylaxis 
 PONV  as needed 
 
Billingham & Role of N2O in Review article N2O remains 
Smith ambulatory  a valuable 
(2014) anesthesia  agent 
 
Ewart Effect of N2O Literature No definitive 
(2010) on PONV review conclusion 
 
Gupta et al. Affect of  Systematic review Treatment 
(2003) prophylactic of randomized significantly 
 antiemetics on controlled trials reduces  
 PONV  PONV 
 
Joshi Optimizing Review article No convincing 
(2013) perioperative care  reason to  
 for rapid recovery  avoid N2O 
 
Joshi & Clinical Textbook 
Cunningham education 
(2013) 
 
Kariman et al. Effectiveness of Randomized trial No difference 
(2011) N2O in relieving of 100 patients between N2O 
 pain  and fentanyl in 
   relieving pain 
 
Myles et al. Risks and benefits Review article Conclusive  
(2004) of N2O  data is lacking 
 
  
42 
 
 
   
 
Author & Objective Design & Sample Findings 
Date 
 
 
Nagelhout Clinical Textbook 
(2014) education 
 
O' Sullivan & Capabilities for Review article Versatile and 
Benger emergency  effective as an 
(2003) medicine  analgesic 
   agent 
 
Parbrook et al. Potency of N2O Vital capacity was Improvement  
(1964) compared to compared for N2O in vital  
 morphine and morphine to  capacity and 
  measure pain relief peak flow was 
   better w/ N2O 
 
Peyton et al. Second gas effect Randomized trial Elimination of 
(2011) on emergence of 20 patients  N2O increases 
 from anesthesia undergoing the speed of 
  surgery emergence 
 
Pueyo et al. Cost-effectiveness Prospective Greater  
(2003) of antiemetics in double-blind satisfaction w/ 
 preventing PONV study of ninety prophylactic 
  females antiemetics 
 
Tramer et al. Comparison of Meta-analytic N2O with  
(1997) prophylactic comparison of 3 propofol 
 antiemetic efficacy different methods reduces the  
   risk of  
   awareness and 
   decreased cost 
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APPENDIX I 
 
LITERATURE REVIEW TABLE 
 
THEORETICAL FOUNDATION 
 
 
Author & Objective Design & Sample Findings 
Date 
 
 
Anderson Theoretical  Textbook Quality is 
(2011) approach to quality  driven by 
 improvement  leaders 
 
Burkart-Jayez Utilize information Textbook Balance 
(2011) systems to  innovation to 
 transform healthcare  improve care 
 
Churchman Using a systems Working paper Improvement 
(1973) design for   is achieved 
 improvement  through 
   planning and 
   reflection 
 
Donabedian Assessing the Review article To assess 
(1988) quality of care  quality one 
   must have  
   evaluate the 
   structure and 
   process 
 
Edwardson Review of  Review of 49 Frameworks 
(2007) conceptual  different studies especially  
 frameworks used  useful to nurse 
 in research  investigations 
 
Eldridge Scientific Textbook Every nurse 
(2011) underpinnings for  operates from 
 practice  philosophical 
   and theoretical 
   base 
 
Goodson What is theory Textbook Predict 
(2011) and what does it do  behavior 
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Author & Objective Design & Sample Findings 
Date 
 
 
Institute of Medicine Recommendations White Paper Policy change 
(2011) for the future of  to promote 
 of nursing  future  
   generations 
 
National League Recommendations Position Increasing  
for Nursing for the faculty role  Statement education of 
(2015) in preparing  informatics 
 students for  
 technology 
 
Peplau Understanding the Review article Interaction 
(1997) relationship b/w  between two 
 client and nurse  individuals  
   with a  
   common goal 
 
Peterson Transforming the Textbook Systems  
(2011) healthcare system  thinking to  
   optimize  
   results for 
   maximum  
   results 
 
Tymkow Understanding Textbook Intellectual 
(2011) clinical scholarship  process of 
   developing  
   new 
   knowledge 
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APPENDIX J 
 
DNP ESSENTIALS 
 
 
 DNP Essential Capstone Relation 
 
 
I. Scientific underpinnings for practice This project utilizes Peplau's theory of  
   interpersonal relations in order to reach a 
   mutual goal by defining the problem,  
   clarifying the expectations, and exploiting 
   a different practice technique to develop 
   a solution. 
 
II.   Organizational and systems Donabedian's simplified systems model for  
 leadership for quality improvement total quality management was utilized in this 
 and systems thinking project in an attempt to improve quality 
   outcomes in the most efficient manner 
   possible.  This was done by improving both 
   the structure and process, thereby improving 
   the outcome 
 
III. Clinical leadership and analytical In order to evaluate the significance of this 
 methods for evidence-based project, the results were compared to the  
 practice  national average using numerous statistical 
   methods and showed tremendously better  
   outcomes. 
 
IV. Information systems/technology and The EPIC software system was used in this 
 patient care technology for the  project for data collection and as a result,  
 improvement and transformation of new updates will be added to the system in  
 health care  January of 2016 to improve data extraction 
   and information management. 
 
V. Health care policy for advocacy in  Annual trips were made to both the 
 health care  national and state capital buildings to attend 
   meetings regarding healthcare policy and  
   access to care.  This author personally  
   contacted and discussed national drug 
   shortages with U.S. Senators to provide 
   insight and recommendations. 
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  DNP Essentials  Capstone Relation 
 
 
VI. Interpersonal collaboration for This project was developed and 
 improving patient and population implemented only through the help and 
 health outcomes  collaboration of mentors and peers. 
   Following conclusion of this project, results 
   will be presented at the monthly anesthesia 
   conference at Keesler AFB. 
 
VII. Clinical prevention and population Development of this project stemmed from 
 health for improving the nations the overwhelming incidence of PONV 
 health  following surgery and anesthesia.  The 
   results of this project show significant 
   promise for improving surgical outcomes 
   and expectations while decreasing overall 
   costs. 
 
VIII. Advance nursing practice The sole purpose of this project was to 
   improve patient satisfaction and outcomes 
   while also meeting fiscal and provider 
   expectations.  Utilization of nitrous oxide 
   with a decreased incidence of PONV can 
   significantly improve anesthesia and 
   surgical outcomes while greatly reducing 
   costs and utilization of resources. 
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APPENDIX K 
 
PROJECTED TIMELINE 
 
 
Requirement Start Complete Dependent 
 
 
Topic & Jan. 14, 2014 Apr. 3, 2015 Approval from  
Literature   Committee chair 
Review 
 
Citi Training Jan. 14, 2014 Feb. 2, 2014 
 
Preliminary  Oct. 13, 2014 Apr. 5, 2015 Approval from 
Proposal   Committee chair 
 
Submit the Oct. 13, 2014 Oct. 15, 2014 Approval from  
Graduate   Graduate school and 
Committee request   committee members 
form 
 
Contact  Oct. 15, 2014 Oct. 18, 2014 Approval from 
Graduate Reader   Graduate reviewer 
 
Submit final Apr. 5, 2015 Apr. 18, 2015 Completion of 
outline of    literature review and 
Capstone   committee chair 
   approval 
 
Capstone draft Apr. 13, 2015 Apr. 19, 2015 Completion of 
submission to   literature review and 
committee   committee chair 
   approval 
 
Proposal Defense Apr. 23, 2015 May 3, 2015 Committee approval  
Meeting   of final outline and 
   draft 
 
Prospectus from May 3, 2015 May 8, 2015 Successful defense of 
submitted to auditor   capstone proposal 
 
Submit title page May 9, 2015 May 12, 2015 Committee approval 
for approval   of proposal defense 
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Requirement Start Complete Dependent 
 
 
IRB submissions May 28, 2015 July 27, 2015 Exemption approval 
& approvals   from FGH and USM 
   IRB committee's 
 
Implementation July 28, 2015 Sept. 3, 2015 Extraction, collection 
of project   and analysis of all 
   relevant data to the 
   project 
 
Oral Defense of Sept. 22, 2015 Sept. 25, 2015 Submission and 
Capstone project   committee approval 
   of final capstone 
   draft  
 
Submit results Sept. 25, 2015 Sept. 28, 2015 Successful defense 
of oral defense   and approval of 
to graduate   capstone project 
auditor 
 
Submit capstone Sept. 28, 2015 Oct. 5, 2015 Successful oral 
project to reviewer   defense of capstone 
for proofing and   project 
approval 
 
Submit two final Sept. 28, 2015 Oct. 5, 2015 Successful oral  
signed title pages   defense and approval 
to graduate reviewer   of capstone project 
 
Submit final  
reviewer approved Oct. 5, 2015 Oct. 12, 2015 Completion of final 
copies of capstone   revision and graduate 
project   reviewer approval 
 
Comprehensive  Oct. 16, 2015 Oct. 20, 2015 Completion of exam 
exam results    
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